DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Emens L, Loi S, Rugo HS. et al.
Abstract GS1-04: IMpassion130: Efficacy in immune biomarker subgroups from the global, randomized, double-blind, placebo-controlled, phase III study of atezolizumab + nab-paclitaxel in patients with treatment-naïve, locally advanced or metastatic triple-negative breast cancer.
Cancer Res 2019;
79 (4 Suppl.): GS1-04
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.